New Research Collaboration Agreement (RCA) between Prous Institute and the FDA-CFSAN (Center for Food Safety and Applied Nutrition) Washington D.C., USA: The Food and Drug Administration's Center for Food Safety and Applied Nutrition(FDA/CFSAN) and Prous Institute for Biomedical Re...
Prous Institute Presents Its Progress in Cardiotoxicity Modeling at the SOT 2011 Washington D.C., USA: Prous Institute for Biomedical Research will be jointly presenting a scientific poster with the US FDA Center for Drug Evaluatio...
SOT 2011: “In Silico Predictive Model for Drug-Induced Phospholipidosis using BioEpisteme software" Washington D.C., USA: Prous Institute’s BioEpisteme® software will be featured in a scientific poster to be presented by the US FDA Center f...
Prediction of Drug-Related Cardiac Adverse Effects in Humans--A: Creation of a Database of Effects and Identification of Factors Affecting their Occurrence. Authors: Matthews EJ, Frid AA. Journal: Regul Toxicol Pharmacol. 2010 Apr;56(3):247-75., PMID: 19932726 Link to Article
Prediction of Drug-Related Cardiac Adverse Effects in Humans--B: Use of QSAR Programs for Early Detection of Drug-Induced Cardiac Toxicities Authors: Frid AA, Matthews EJ Journal: Regul Toxicol Pharmacol. 2010 Apr;56(3):276-89., PMID: 19941924 Link to Article